Upadacitinib

Brevis descriptio:

API Nomen Indicium Innovator Exitus patentibus Date (US)
Upadacitinib Dermatitis atopic ABBVIE INC Dec.01,2030


Product Detail

Product Tags


  • Priora:
  • Next:

  • Epistulam tuam hic scribe et mitte nobis